Publicaciones en colaboración con investigadores/as de Universidad CEU San Pablo (13)

2023

  1. Mapping early serum proteome signatures of liver regeneration in living donor liver transplant cases

    BioFactors, Vol. 49, Núm. 4, pp. 912-927

  2. Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution

    Frontiers in Immunology, Vol. 14

2022

  1. Broad virus inactivation using inorganic micro/nano-particulate materials

    Materials Today Bio, Vol. 13

  2. Hematological-and Immunological-Related Biomarkers to Characterize Patients with COVID-19 from Other Viral Respiratory Diseases

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  3. Targeting Signaling Pathway Downstream of RIG-I/MAVS in the CNS Stimulates Production of Endogenous Type I IFN and Suppresses EAE

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

    Journal of Clinical Investigation, Vol. 131, Núm. 20

  2. CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis

    Journal of Hepatology, Vol. 75, Núm. 3, pp. 600-609

  3. Linking the Expression of Therapeutic Genes to Unfolded Protein Response: A New Option for Anti-Hepatitis B Virus Gene Therapy

    Human Gene Therapy, Vol. 32, Núm. 7-8, pp. 341-348

2017

  1. Experimental approach to IGF-1 therapy in CCl4-induced acute liver damage in healthy controls and mice with partial IGF-1 deficiency

    Journal of Translational Medicine, Vol. 15, Núm. 1

  2. IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture

    Journal of Physiology and Biochemistry, Vol. 73, Núm. 2, pp. 245-258

2016

  1. A versatile vector for in vivo monitoring of type I interferon induction and signaling

    PLoS ONE, Vol. 11, Núm. 3

  2. Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense

    Nature Immunology, Vol. 17, Núm. 9, pp. 1037-1045

2010

  1. Smoking but not homozygosity for CYP1A2 g-163A allelic variant leads to earlier disease onset in patients with sporadic porphyria cutanea tarda

    Experimental Dermatology